Yoshida S
National Cancer Center Hospital East, Chiba, Japan.
Digestion. 1998 Aug;59(5):502-8. doi: 10.1159/000007527.
Due to the recent widespread use of detailed endoscopy together with careful scrutiny of the mucosa using dye-spraying techniques, there has been a general acceptance in Japan that early malignancies in the alimentary tract may not appear polypoid or ulcerative. Regardless of organ, superficial early cancers have been reported. These lesions appear as faint mucosal irregularities or discolorations, which may be difficult to distinguish from nonspecific inflammation or trauma. The recognition of these malignancies has prompted the development of new techniques for their treatment. Endoscopic mucosal resection (EMR) which can resect lesions as completely as specimens removed at open surgery, has become the first choice of treatment for early digestive cancer. The lesions that can be removed by EMR should be those which hardly ever carry lymph node metastases. Endoscopically, they are shown to be flat esophageal cancers, gastritis-like cancers and colorectal cancers less than 2 cm in flat elevated type or less than 1 cm in depressed type. In spite of the advances in characterizing early cancers and an emerging consensus on indications and contraindications for EMR, much work remains to be done. New techniques will continue to push the limits of what can be achieved via an endoscope.
由于近期详细内镜检查的广泛应用以及采用染料喷洒技术对黏膜进行仔细检查,在日本,人们普遍接受消化道早期恶性肿瘤可能并非呈息肉样或溃疡性。无论累及哪个器官,均有浅表性早期癌症的报道。这些病变表现为黏膜轻度不规则或变色,可能难以与非特异性炎症或创伤相区分。对这些恶性肿瘤的认识促使了其治疗新技术的发展。内镜黏膜切除术(EMR)能够像开放手术切除标本一样完整地切除病变,已成为早期消化道癌的首选治疗方法。可通过EMR切除的病变应是极少发生淋巴结转移的病变。在内镜下,它们表现为平坦型食管癌、胃炎样癌以及平坦隆起型小于2 cm或凹陷型小于1 cm的结直肠癌。尽管在早期癌症特征描述方面取得了进展,且对于EMR的适应证和禁忌证也逐渐达成共识,但仍有许多工作要做。新技术将继续拓展通过内镜所能达到的极限。